Comparing Bromocriptine vs Letrozole
Bromocriptine | Letrozole |
|
---|
Bromocriptine | Letrozole |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hyperprolactinemia, Acromegaly, Type 2 Diabetes, Parkinson's Disease, Tardive Dyskinesia. Bromocriptine may also be used for purposes not listed in this medication guide. |
Prescription only
Letrozole (brand name Femara) is a treatment that may be used to reduce the risk of breast cancer recurrence in postmenopausal women and also to increase the chance of ovulation in women with... View more |
||||||||||||||||
More about Bromocriptine | More about Letrozole | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Bromocriptine has an average rating of 5.9 out of 10 from a total of 41 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 39% reported a negative effect. |
Letrozole has an average rating of 6.5 out of 10 from a total of 367 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Bromocriptine side effects |
View all Letrozole side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Bromocriptine prices |
View all Letrozole prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Cycloset, Parlodel | Femara | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
8 hours |
48 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 459 drugs are known to interact with Bromocriptine:
|
A total of 121 drugs are known to interact with Letrozole:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
June 28, 1978 |
July 25, 1997 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Parlodel
Parlodel is used for acromegaly, hyperprolactinemia, parkinson's disease
Cycloset
Cycloset is used to treat Type 2 Diabetes. Learn about side effects, interactions and indications.
Nuplazid
Nuplazid (pimavanserin) is an antipsychotic medicine used to treat hallucinations and delusions in ...
Pergolide
Pergolide is used for hyperprolactinemia, parkinson's disease, tourette's syndrome
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.